Review highlights pharmacological treatments and their impact on attention-deficit/hyperactivity disorder in all ages, suggesting combination therapies may offer the best outcomes.
There is a significant body of research on the topic of treatments for attention-deficit/hyperactivity disorder in children, adolescents, and adults. Major pharmacological treatments include stimulants (amphetamines and methylphenidate) and non-stimulants (atomoxetine and others). There are also forms of non-pharmacological treatment, including behavioral and psychosocial therapies. Studies have demonstrated the most improvement in functioning and reduction of symptoms because of a combination of pharmacological and behavioral treatment, however on its own, medication management has proven to be significantly more effective than behavioral therapy strategies. This review covers recent trends in Treatments and Pharmacology of Attention-Deficit/Hyperactivity Disorder.
No takes yet. Share an insight, caveat, or question.
Yashwant Pathak (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: